Control Group:placebo (contain 5% test drug)

2 trials

Sponsors

Beijing University of Chinese Medicine

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000031672

Beijing University of Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-04-01Updated: 2020-09-14

Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)

Active, not recruitingITMCTR2000003188

Beijing University of Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-04-01Updated: 2023-02-20